SGCB and chronic kidney disease: In complex HF phenotypes—such as HFrEF with CKD or pulmonary hypertension—NO-sGC-cGMP modulators can serve as early adjuncts or even initial therapeutic steps, especially when GDMT is limited by hypotension or renal impairment.